Erik A. Williams, M.D.
Erik A. Williams, M.D.
Foundation Medicine Inc., UCSF
Verified email at ucsf.edu
Title
Cited by
Cited by
Year
Reliability and convergent validity of two outcome instruments for pemphigus
M Rosenbach, DF Murrell, JC Bystryn, S Dulay, S Dick, S Fakharzadeh, ...
Journal of investigative dermatology 129 (10), 2404-2410, 2009
1822009
The diagnostic use of immunohistochemical surrogates for signature molecular genetic alterations in gliomas
J Tanboon, EA Williams, DN Louis
Journal of Neuropathology & Experimental Neurology 75 (1), 4-18, 2016
702016
Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomas
TA Juratli, C Thiede, MVA Koerner, SS Tummala, D Daubner, ...
Oncotarget 8 (65), 109228, 2017
582017
Srcasm inhibits Fyn-induced cutaneous carcinogenesis with modulation of Notch1 and p53
L Zhao, W Li, C Marshall, T Griffin, M Hanson, R Hick, T Dentchev, ...
Cancer research 69 (24), 9439-9447, 2009
492009
DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome
TA Juratli, D McCabe, N Nayyar, EA Williams, IM Silverman, SS Tummala, ...
Acta neuropathologica 136 (5), 779-792, 2018
432018
Absence of Alzheimer disease neuropathologic changes in eyes of subjects with Alzheimer disease
EA Williams, D McGuone, MP Frosch, BT Hyman, N Laver, ...
Journal of Neuropathology & Experimental Neurology 76 (5), 376-383, 2017
352017
Genotype-targeted local therapy of glioma
GM Shankar, AR Kirtane, JJ Miller, H Mazdiyasni, J Rogner, T Tai, ...
Proceedings of the National Academy of Sciences 115 (36), E8388-E8394, 2018
272018
PI3K/AKT/mTOR pathway alterations promote malignant progression and xenograft formation in oligodendroglial tumors
K Tateishi, T Nakamura, TA Juratli, EA Williams, Y Matsushita, S Miyake, ...
Clinical Cancer Research 25 (14), 4375-4387, 2019
182019
Accelerated progression of IDH mutant glioma after first recurrence
JJ Miller, F Loebel, TA Juratli, SS Tummala, EA Williams, TT Batchelor, ...
Neuro-oncology 21 (5), 669-677, 2019
182019
A pan-cancer analysis of PD-L1 immunohistochemistry and gene amplification, tumor mutation burden and microsatellite instability in 48,782 cases
RSP Huang, J Haberberger, E Severson, DL Duncan, A Hemmerich, ...
Modern Pathology 34 (2), 252-263, 2021
172021
Histone H3K27 dimethyl loss is highly specific for malignant peripheral nerve sheath tumor and distinguishes true PRC2 loss from isolated H3K27 trimethyl loss
DM Marchione, A Lisby, AN Viaene, M Santi, ML Nasrallah, LP Wang, ...
Modern Pathology 32 (10), 1434-1446, 2019
172019
Histiocytic sarcoma of the cavernous sinus: case report and literature review
CJ Chen, EA Williams, TE McAneney, BJ Williams, JW Mandell, ...
Brain tumor pathology 32 (1), 66-71, 2015
172015
Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic
EA Williams, S Santagata, H Wakimoto, GM Shankar, FG Barker, R Sharaf, ...
Acta neuropathologica communications 8 (1), 1-10, 2020
102020
TERT promoter wild-type glioblastomas show distinct clinical features and frequent PI3K pathway mutations
EA Williams, JJ Miller, SS Tummala, T Penson, AJ Iafrate, TA Juratli, ...
Acta neuropathologica communications 6 (1), 1-6, 2018
102018
Pan-Cancer Landscape Analysis Reveals Recurrent KMT2A-MAML2 Gene Fusion in Aggressive Histologic Subtypes of Thymoma
LR Massoth, YP Hung, D Dias-Santagata, M Onozato, N Shah, ...
JCO precision oncology 4, 109-115, 2020
92020
Factors associated with false‐negative pathologic diagnosis of calciphylaxis
EA Williams, AP Moy, NA Cipriani, SU Nigwekar, RM Nazarian
Journal of cutaneous pathology 46 (1), 16-25, 2019
92019
Pan-sarcoma genomic analysis of KMT2A rearrangements reveals distinct subtypes defined by YAP1–KMT2A–YAP1 and VIM–KMT2A fusions
LR Massoth, YP Hung, V Nardi, GP Nielsen, RP Hasserjian, A Louissaint, ...
Modern Pathology 33 (11), 2307-2317, 2020
62020
Melanomas with activating RAF1 fusions: clinical, histopathologic, and molecular profiles
EA Williams, N Shah, M Montesion, R Sharaf, DC Pavlick, ES Sokol, ...
Modern Pathology 33 (8), 1466-1474, 2020
62020
Frequent inactivating mutations of the PBAF complex gene PBRM1 in meningioma with papillary features
EA Williams, W Hiroaki, GM Shankar, FG Barker II, PK Brastianos, ...
Acta neuropathologica 140 (1), 89-93, 2020
62020
Vulvar Squamous Cell Carcinoma: Comprehensive Genomic Profiling of HPV+ Versus HPV–Forms Reveals Distinct Sets of Potentially Actionable Molecular Targets
EA Williams, AJ Werth, R Sharaf, M Montesion, ES Sokol, DC Pavlick, ...
JCO Precision Oncology 4, 647-661, 2020
62020
The system can't perform the operation now. Try again later.
Articles 1–20